{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:35:12Z","timestamp":1789943712781,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00223-016-0231-6","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T02:30:48Z","timestamp":1488249048000},"page":"551-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt\/\u03b2-Catenin Signaling Pathway"],"prefix":"10.1007","volume":"100","author":[{"given":"Jian","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"231_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2012.05.028","volume":"338","author":"U Basu-Roy","year":"2013","unstructured":"Basu-Roy U, Basilico C, Mansukhani A (2013) Perspectives on cancer stem cells in osteosarcoma. Cancer Lett 338:158\u2013167","journal-title":"Cancer Lett"},{"key":"231_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1586\/14737140.7.2.169","volume":"7","author":"F Lamoureux","year":"2007","unstructured":"Lamoureux F, Trichet V, Chipoy C, Blanchard F, Gouin F, Redini F (2007) Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. Expert Rev Anticancer Ther 7:169\u2013181","journal-title":"Expert Rev Anticancer Ther"},{"key":"231_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115:1531\u20131543","journal-title":"Cancer"},{"key":"231_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11999-015-4620-3","volume":"474","author":"EF Peterse","year":"2016","unstructured":"Peterse EF, Bovee JV (2016) CORR Insights((R)): Transcriptional profiling identifies the signaling axes of IGF and transforming growth factor-beta as involved in the pathogenesis of osteosarcoma. Clin Orthop Relat Res 474:190\u2013192","journal-title":"Clin Orthop Relat Res"},{"key":"231_CR5","first-page":"55","volume":"9","author":"JD Lamplot","year":"2013","unstructured":"Lamplot JD, Denduluri S, Qin J, Li R, Liu X, Zhang H, Chen X, Wang N, Pratt A, Shui W, Luo X, Nan G, Deng ZL, Luo J, Haydon RC, He TC, Luu HH (2013) The current and future therapies for human osteosarcoma. Curr Cancer Ther Rev 9: 55\u201377.","journal-title":"Curr Cancer Ther Rev"},{"key":"231_CR6","doi-asserted-by":"publisher","first-page":"11365","DOI":"10.1038\/srep11365","volume":"5","author":"Y Gao","year":"2015","unstructured":"Gao Y, Y Feng, JK Shen, M Lin, E Choy, GM Cote, DC Harmon, HJ Mankin, FJ Hornicek, Z Duan (2015) CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma. Sci Rep 5: 11365.","journal-title":"Sci Rep"},{"key":"231_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13075-015-0540-6","volume":"17","author":"W Bouaziz","year":"2015","unstructured":"Bouaziz W, Funck-Brentano T, Lin H, Marty C, Ea HK, Hay E, Cohen-Solal M (2015) Loss of sclerostin promotes osteoarthritis in mice via beta-catenin-dependent and -independent Wnt pathways. Arthritis Res Ther 17:24","journal-title":"Arthritis Res Ther"},{"key":"231_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000444634","volume":"201","author":"B Sedaghati","year":"2016","unstructured":"Sedaghati B, Jahroomishirazi R, Starke A, Hacker MC, Schulz-Siegmund M (2016) Rat osteosarcoma cells as a therapeutic target model for osteoregeneration via sclerostin knockdown. Cells Tissues Organs 201:366\u2013379.","journal-title":"Cells Tissues Organs"},{"key":"231_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/jcpe.12245","volume":"41","author":"MH Napimoga","year":"2014","unstructured":"Napimoga MH, Nametala C, da Silva FL, Miranda TS, Bossonaro JP, Demasi AP, Duarte PM (2014) Involvement of the Wnt-beta-catenin signalling antagonists, sclerostin and dickkopf-related protein 1, in chronic periodontitis. J Clin Periodontol 41:550\u2013557","journal-title":"J Clin Periodontol"},{"key":"231_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/labinvest.2015.144","volume":"96","author":"K Yang","year":"2016","unstructured":"Yang K, Wang X, Zhang H, Wang Z, Nan G, Li Y, Zhang F, Mohammed MK, Haydon RC, Luu HH, Bi Y, He TC (2016) The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Investig 96:116\u2013136","journal-title":"Lab Investig"},{"key":"231_CR11","doi-asserted-by":"publisher","first-page":"e1005638","DOI":"10.1371\/journal.pgen.1005638","volume":"11","author":"Y Feng","year":"2015","unstructured":"Feng Y, Sakamoto N, Wu R, Liu JY, Wiese A, Green ME, Green M, Akyol A, Roy BC, Zhai Y, Cho KR, Fearon ER (2015) Tissue-specific effects of reduced beta-catenin expression on adenomatous polyposis coli mutation-instigated tumorigenesis in mouse colon and ovarian epithelium. PLoS Genet 11:e1005638","journal-title":"PLoS Genet"},{"key":"231_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.biocel.2009.09.001","volume":"43","author":"SP Monga","year":"2011","unstructured":"Monga SP (2011) Role of Wnt\/beta-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol 43:1021\u20131029","journal-title":"Int J Biochem Cell Biol"},{"key":"231_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1476-4598-9-236","volume":"9","author":"T Hu","year":"2010","unstructured":"Hu T, Li C (2010) Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 9:236","journal-title":"Mol Cancer"},{"key":"231_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3892\/ijo.2014.2456","volume":"45","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu YZ, Zhang RX, Wang X, Meng ZJ, Huang J, Wu K, Luo JY, Zuo GW, Chen L, Yin LJ, Deng ZL, He BC (2014) Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt\/beta-catenin signaling. Int J Oncol 45:795\u2013803","journal-title":"Int J Oncol"},{"key":"231_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1586\/era.11.94","volume":"11","author":"P McQueen","year":"2011","unstructured":"McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH (2011) The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Rev Anticancer Ther 11:1223\u20131232","journal-title":"Expert Rev Anticancer Ther"},{"key":"231_CR16","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D (2005) Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883\u201319887","journal-title":"J Biol Chem"},{"key":"231_CR17","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1074\/jbc.M504308200","volume":"280","author":"M Semenov","year":"2005","unstructured":"Semenov M, Tamai K, He X (2005) SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280:26770\u201326775","journal-title":"J Biol Chem"},{"key":"231_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1210\/er.2011-1060","volume":"33","author":"HZ Ke","year":"2012","unstructured":"Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33:747\u2013783","journal-title":"Endocr Rev"},{"key":"231_CR19","doi-asserted-by":"publisher","first-page":"14923","DOI":"10.1007\/s13277-016-5401-7","volume":"37","author":"ZX Liu","year":"2016","unstructured":"Liu ZX, Hong L, Fang SQ, Tan GH, Huang PG, Zeng Z, Xia X, Wang XX (2016) Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma. Tumour Biol 37:14923\u201314928","journal-title":"Tumour Biol"},{"key":"231_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00223-014-9880-5","volume":"95","author":"FM Perez-Campo","year":"2014","unstructured":"Perez-Campo FM, Sanudo C, Delgado-Calle J, Arozamena J, Zarrabeitia MT, Riancho JA (2014) A Sclerostin super-producer cell line derived from the human cell line SaOS-2: a new tool for the study of the molecular mechanisms driving Sclerostin expression. Calcif Tissue Int 95:194\u2013199","journal-title":"Calcif Tissue Int"},{"key":"231_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/his.12953","volume":"69","author":"Y Inagaki","year":"2016","unstructured":"Inagaki Y, Hookway ES, Kashima TG, Munemoto M, Tanaka Y, Hassan AB, Oppermann U, Athanasou NA (2016) Sclerostin expression in bone tumours and tumour-like lesions. Histopathology 69:470\u2013478","journal-title":"Histopathology"},{"key":"231_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.fct.2014.08.013","volume":"74","author":"Y Yang","year":"2014","unstructured":"Yang Y, Yang JJ, Tao H, Jin WS (2014) New perspectives on beta-catenin control of cell fate and proliferation in colon cancer. Food Chem Toxicol 74:14\u201319","journal-title":"Food Chem Toxicol"},{"key":"231_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/path.2628","volume":"220","author":"Y Cai","year":"2010","unstructured":"Cai Y, Mohseny AB, Karperien M, Hogendoorn PC, Zhou G, Cleton-Jansen AM (2010) Inactive Wnt\/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 220:24\u201333","journal-title":"J Pathol"},{"key":"231_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577\u2013589","journal-title":"Am J Hum Genet"},{"key":"231_CR25","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1210\/en.2007-0270","volume":"148","author":"R Baron","year":"2007","unstructured":"Baron R, Rawadi G (2007) Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635\u20132643","journal-title":"Endocrinology"},{"key":"231_CR26","first-page":"1126","volume":"55","author":"H Zhang","year":"2008","unstructured":"Zhang H, Xue Y (2008) Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology 55:1126\u20131130","journal-title":"Hepatogastroenterology"},{"key":"231_CR27","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1210\/en.2003-1492","volume":"145","author":"Y Ohyama","year":"2004","unstructured":"Ohyama Y, Nifuji A, Maeda Y, Amagasa T, Noda M (2004) Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis. Endocrinology 145:4685\u20134692","journal-title":"Endocrinology"},{"key":"231_CR28","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.18632\/oncotarget.3609","volume":"6","author":"X Chen","year":"2015","unstructured":"Chen X, Song X, Yue W, Chen D, Yu J, Yao Z, Zhang L (2015) Fibulin-5 inhibits Wnt\/beta-catenin signaling in lung cancer. Oncotarget 6:15022\u201315034","journal-title":"Oncotarget"},{"key":"231_CR29","doi-asserted-by":"publisher","unstructured":"Blum D, H Hao, M McCarthy, and B Reproducibility Project: Cancer (2015) Registered report: transcriptional amplification in tumor cells with elevated c-Myc. Elife 4:e04024","DOI":"10.7554\/eLife.04024"},{"key":"231_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ccr.2012.09.015","volume":"22","author":"XLi Choi YJ","year":"2012","unstructured":"Choi YJ, X Li, Hydbring P, Sanda T, Stefano J, Christie AL, Signoretti S, Look AT, Kung AL, von Boehmer H, Sicinski P (2012) The requirement for cyclin D function in tumor maintenance. Cancer Cell 22:438\u2013451","journal-title":"Cancer Cell"},{"key":"231_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9\u201334","journal-title":"Cancer Metastasis Rev"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0231-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:58:16Z","timestamp":1568854696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0231-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0231-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}